Confirmatory Efficacy Trial of Attention Bias Modification for Depression - Trial NCT06361095
Access comprehensive clinical trial information for NCT06361095 through Pure Global AI's free database. This Phase 1 trial is sponsored by University of Texas at Austin and is currently Not yet recruiting. The study focuses on Depression. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Texas at Austin
Timeline & Enrollment
Phase 1
May 01, 2024
Mar 01, 2028
Primary Outcome
QIDS (Quick Inventory of Depression Symptoms) SR-16
Summary
The goal of this clinical trial is to compare the efficacy of two related, but different ABM
 (Attention Biased Modification) treatments for depression in adults with elevated symptoms of
 depression. The main aims are:
 
 - Aim 1:examine whether gamified ABM leads to greater change in the primary and secondary
 outcomes than sham ABM
 
 - Aim 1: establish that gamified ABM is at least as effective as traditional ABM.
 
 - Aim 2: identify moderators of ABM efficacy and mechanisms responsible for its efficacy.
 
 - Aim 3: Identify the durability of ABM on depression symptoms during short-term follow-up
 
 Participants will complete self-report questionnaires, complete eye-tracking tasks, and be
 clinically assessed through interviews by clinician researchers.
 
 If there is a comparison group: Researchers will compare sham, traditional, and gamified
 treatment groups to see if they moderate symptoms of depression.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06361095
Non-Device Trial